These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 16537592

  • 1. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.
    Melikyan GB, Egelhofer M, von Laer D.
    J Virol; 2006 Apr; 80(7):3249-58. PubMed ID: 16537592
    [Abstract] [Full Text] [Related]

  • 2. The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle.
    Abrahamyan LG, Mkrtchyan SR, Binley J, Lu M, Melikyan GB, Cohen FS.
    J Virol; 2005 Jan; 79(1):106-15. PubMed ID: 15596806
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.
    Cai L, Gochin M.
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2388-95. PubMed ID: 17452484
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD.
    AIDS Rev; 2003 Jul; 5(4):214-21. PubMed ID: 15012000
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergistic inhibition of HIV-1 envelope-mediated membrane fusion by inhibitors targeting the N and C-terminal heptad repeats of gp41.
    Gustchina E, Louis JM, Bewley CA, Clore GM.
    J Mol Biol; 2006 Dec 01; 364(3):283-9. PubMed ID: 17010381
    [Abstract] [Full Text] [Related]

  • 8. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
    Golding H, Zaitseva M, de Rosny E, King LR, Manischewitz J, Sidorov I, Gorny MK, Zolla-Pazner S, Dimitrov DS, Weiss CD.
    J Virol; 2002 Jul 01; 76(13):6780-90. PubMed ID: 12050391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.
    Miyauchi K, Kozlov MM, Melikyan GB.
    PLoS Pathog; 2009 Sep 01; 5(9):e1000585. PubMed ID: 19763181
    [Abstract] [Full Text] [Related]

  • 11. Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.
    Cai L, Gochin M, Liu K.
    Curr Top Med Chem; 2011 Dec 01; 11(24):2959-84. PubMed ID: 22044229
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O, Sackett K, Shai Y.
    J Mol Biol; 2006 Dec 15; 364(5):1103-17. PubMed ID: 17045292
    [Abstract] [Full Text] [Related]

  • 15. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.
    Shu W, Liu J, Ji H, Radigen L, Jiang S, Lu M.
    Biochemistry; 2000 Feb 22; 39(7):1634-42. PubMed ID: 10677212
    [Abstract] [Full Text] [Related]

  • 16. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S, Zhao Q, Debnath AK.
    Curr Pharm Des; 2002 Feb 22; 8(8):563-80. PubMed ID: 11945159
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor.
    Yu D, Ding X, Liu Z, Wu X, Zhu Y, Wei H, Chong H, Cui S, He Y.
    J Biol Chem; 2018 Aug 17; 293(33):12703-12718. PubMed ID: 29929981
    [Abstract] [Full Text] [Related]

  • 20. Addition of artificial salt bridge by Ile646Lys mutation in gp41 coiled-coil domain regulates 6-helical bundle formation.
    Zhao L, Hu ZW, Tong P, Chen YX, Zhao YF, Li YM.
    Bioorg Med Chem Lett; 2013 May 01; 23(9):2727-32. PubMed ID: 23522564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.